Skip to main content
Erschienen in: Current HIV/AIDS Reports 1/2011

01.03.2011

Combination HIV Prevention: Significance, Challenges, and Opportunities

verfasst von: Ann E. Kurth, Connie Celum, Jared M. Baeten, Sten H. Vermund, Judith N. Wasserheit

Erschienen in: Current HIV/AIDS Reports | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

No single HIV prevention strategy will be sufficient to control the HIV pandemic. However, a growing number of interventions have shown promise in partially protecting against HIV transmission and acquisition, including knowledge of HIV serostatus, behavioral risk reduction, condoms, male circumcision, needle exchange, treatment of curable sexually transmitted infections, and use of systemic and topical antiretroviral medications by both HIV-infected and uninfected persons. Designing the optimal package of interventions that matches the epidemiologic profile of a target population, delivering that package at the population level, and evaluating safety, acceptability, coverage, and effectiveness, all involve methodological challenges. Nonetheless, there is an unprecedented opportunity to develop “prevention packages” that combine various arrays of evidence-based strategies, tailored to the needs of diverse subgroups and targeted to achieve high coverage for a measurable reduction in population-level HIV transmission. HIV prevention strategies that combine partially effective interventions should be scaled up and evaluated.
Literatur
1.
Zurück zum Zitat WHO, UNAIDS: AIDS epidemic update: December 2009. UNAIDS: Geneva, Switzerland; 2009. WHO, UNAIDS: AIDS epidemic update: December 2009. UNAIDS: Geneva, Switzerland; 2009.
2.
Zurück zum Zitat Vermund SH: Rationale for the testing and use of a partially effective HIV vaccine. AIDS Res Hum Retroviruses 1998, 14(Suppl 3):S321–S323.PubMed Vermund SH: Rationale for the testing and use of a partially effective HIV vaccine. AIDS Res Hum Retroviruses 1998, 14(Suppl 3):S321–S323.PubMed
3.
Zurück zum Zitat Vergidis PI, Falagas ME: Meta-analyses on behavioral interventions to reduce the risk of transmission of HIV. Infect Dis Clin North Am 2009, 23:309–314.CrossRefPubMed Vergidis PI, Falagas ME: Meta-analyses on behavioral interventions to reduce the risk of transmission of HIV. Infect Dis Clin North Am 2009, 23:309–314.CrossRefPubMed
4.
Zurück zum Zitat Johnson WD, et al.: Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men. Cochrane Database Syst Rev 2008, CD001230. Johnson WD, et al.: Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men. Cochrane Database Syst Rev 2008, CD001230.
5.
Zurück zum Zitat Herbst JH, et al.: A meta-analytic review of HIV behavioral interventions for reducing sexual risk behavior of men who have sex with men. J Acquir Immune Defic Syndr 2005, 39:228–241.PubMed Herbst JH, et al.: A meta-analytic review of HIV behavioral interventions for reducing sexual risk behavior of men who have sex with men. J Acquir Immune Defic Syndr 2005, 39:228–241.PubMed
6.
Zurück zum Zitat Crepaz N, Marshall KJ, Aupont LW, et al.: The efficacy of HIV/STI behavioral interventions for African American females in the United States: a meta-analysis. Am J Public Health 2009, 99:2069–2078.CrossRefPubMed Crepaz N, Marshall KJ, Aupont LW, et al.: The efficacy of HIV/STI behavioral interventions for African American females in the United States: a meta-analysis. Am J Public Health 2009, 99:2069–2078.CrossRefPubMed
7.
Zurück zum Zitat Noar SM, Black HG, Pierce LB: Efficacy of computer technology-based HIV prevention interventions: a meta-analysis. AIDS 2009, 23:107–115.CrossRefPubMed Noar SM, Black HG, Pierce LB: Efficacy of computer technology-based HIV prevention interventions: a meta-analysis. AIDS 2009, 23:107–115.CrossRefPubMed
8.
Zurück zum Zitat Crepaz N, Horn AK, Rama SM, et al.: The efficacy of behavioral interventions in reducing HIV risk sex behaviors and incident sexually transmitted disease in black and Hispanic sexually transmitted disease clinic patients in the United States: a meta-analytic review. Sex Transm Dis 2007, 34:319–332.PubMed Crepaz N, Horn AK, Rama SM, et al.: The efficacy of behavioral interventions in reducing HIV risk sex behaviors and incident sexually transmitted disease in black and Hispanic sexually transmitted disease clinic patients in the United States: a meta-analytic review. Sex Transm Dis 2007, 34:319–332.PubMed
9.
Zurück zum Zitat Vergidis PI, Falagas ME, Hamer DH: Meta-analytical studies on the epidemiology, prevention, and treatment of human immunodeficiency virus infection. Infect Dis Clin North Am 2009, 23:295–308.CrossRefPubMed Vergidis PI, Falagas ME, Hamer DH: Meta-analytical studies on the epidemiology, prevention, and treatment of human immunodeficiency virus infection. Infect Dis Clin North Am 2009, 23:295–308.CrossRefPubMed
10.
Zurück zum Zitat Sturt AS, Dokubo EK, Sint TT: Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database Syst Rev 2010, 3:CD008440. Sturt AS, Dokubo EK, Sint TT: Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database Syst Rev 2010, 3:CD008440.
11.
Zurück zum Zitat Siegfried N, et al.: Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev 2009, 2:CD003362. Siegfried N, et al.: Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev 2009, 2:CD003362.
12.
Zurück zum Zitat Chigwedere P, Seage GR, Lee TH, Essex M: Efficacy of antiretroviral drugs in reducing mother-to-child transmission of HIV in Africa: a meta-analysis of published clinical trials. AIDS Res Hum Retroviruses 2008, 24:827–837.CrossRefPubMed Chigwedere P, Seage GR, Lee TH, Essex M: Efficacy of antiretroviral drugs in reducing mother-to-child transmission of HIV in Africa: a meta-analysis of published clinical trials. AIDS Res Hum Retroviruses 2008, 24:827–837.CrossRefPubMed
13.
Zurück zum Zitat Denison JA, O’Reilly KR, Schmid GP, et al.: HIV voluntary counseling and testing and behavioral risk reduction in developing countries: a meta-analysis, 1990–2005. AIDS Behav 2008, 12:363–373.CrossRefPubMed Denison JA, O’Reilly KR, Schmid GP, et al.: HIV voluntary counseling and testing and behavioral risk reduction in developing countries: a meta-analysis, 1990–2005. AIDS Behav 2008, 12:363–373.CrossRefPubMed
14.
Zurück zum Zitat Modjarrad K, Vermund SH: Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis 2010, 10:455–463.CrossRefPubMed Modjarrad K, Vermund SH: Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis 2010, 10:455–463.CrossRefPubMed
15.
Zurück zum Zitat Gowing L, et al.: Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev 2008, 2:CD004145. Gowing L, et al.: Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev 2008, 2:CD004145.
16.
Zurück zum Zitat Buvé A: Track C Epidemiology and Prevention Sciences Rapporteur Summary. In XVIII International AIDS Conference. Vienna: IAS; 2010. Buvé A: Track C Epidemiology and Prevention Sciences Rapporteur Summary. In XVIII International AIDS Conference. Vienna: IAS; 2010.
17.
Zurück zum Zitat Padian NS, McCoy SI, Balkus JE, Wasserheit JN: Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS 2010, 24:621–635.CrossRefPubMed Padian NS, McCoy SI, Balkus JE, Wasserheit JN: Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS 2010, 24:621–635.CrossRefPubMed
18.
Zurück zum Zitat •• Piot P, Bartos M, Larson H, et al.: Coming to terms with complexity: a call to action for HIV prevention. Lancet 2008, 372:845–859. This is a clarion call to utilize the available science and to mobilize an HIV prevention constituency that engages affected communities.CrossRefPubMed •• Piot P, Bartos M, Larson H, et al.: Coming to terms with complexity: a call to action for HIV prevention. Lancet 2008, 372:845–859. This is a clarion call to utilize the available science and to mobilize an HIV prevention constituency that engages affected communities.CrossRefPubMed
19.
Zurück zum Zitat Holtgrave DR: Is the elimination of HIV infection within reach in the United States? Lessons from an epidemiologic transmission model. Public Health Rep 2010, 125:372–376.PubMed Holtgrave DR: Is the elimination of HIV infection within reach in the United States? Lessons from an epidemiologic transmission model. Public Health Rep 2010, 125:372–376.PubMed
20.
Zurück zum Zitat UNAIDS Prevention Reference Group definition. From UNAIDS Taxonomy of HIV Prevention Activities. Discussion draft for UNAIDS HIV Prevention Reference Group meeting. March 2–4, 2009. UNAIDS Prevention Reference Group definition. From UNAIDS Taxonomy of HIV Prevention Activities. Discussion draft for UNAIDS HIV Prevention Reference Group meeting. March 2–4, 2009.
21.
Zurück zum Zitat Wingood GM, DiClemente RJ: The ADAPT-ITT model: a novel method of adapting evidence-based HIV interventions. J Acquir Immune Defic Syndr 2008, 47(Suppl 1):S40–S46.PubMed Wingood GM, DiClemente RJ: The ADAPT-ITT model: a novel method of adapting evidence-based HIV interventions. J Acquir Immune Defic Syndr 2008, 47(Suppl 1):S40–S46.PubMed
22.
Zurück zum Zitat Glasgow RE, Vogt TM, Boles SM: Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health 1999, 89:1322–1327.CrossRefPubMed Glasgow RE, Vogt TM, Boles SM: Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health 1999, 89:1322–1327.CrossRefPubMed
24.
Zurück zum Zitat Wilson D, Halperin DT: “Know your epidemic, know your response”: a useful approach, if we get it right. Lancet 2008, 372:423–426.CrossRefPubMed Wilson D, Halperin DT: “Know your epidemic, know your response”: a useful approach, if we get it right. Lancet 2008, 372:423–426.CrossRefPubMed
25.
Zurück zum Zitat Vandenbruaene M: King Kennard Holmes—chair of the Department of Global Health of The University of Washington. Interviewed by Marc Vandenbruaene. Lancet Infect Dis 2007, 7:516–520.CrossRef Vandenbruaene M: King Kennard Holmes—chair of the Department of Global Health of The University of Washington. Interviewed by Marc Vandenbruaene. Lancet Infect Dis 2007, 7:516–520.CrossRef
26.
Zurück zum Zitat Stoneburner RL, Low-Beer D: Sexual partner reductions explain human immunodeficiency virus declines in Uganda: comparative analyses of HIV and behavioural data in Uganda, Kenya, Malawi, and Zambia. Int J Epidemiol 2004, 33:624.CrossRefPubMed Stoneburner RL, Low-Beer D: Sexual partner reductions explain human immunodeficiency virus declines in Uganda: comparative analyses of HIV and behavioural data in Uganda, Kenya, Malawi, and Zambia. Int J Epidemiol 2004, 33:624.CrossRefPubMed
27.
Zurück zum Zitat Blower SM, Gershengorn HB, Grant RM: A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science 2000, 287:650–654.CrossRefPubMed Blower SM, Gershengorn HB, Grant RM: A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science 2000, 287:650–654.CrossRefPubMed
28.
Zurück zum Zitat •• Granich RM, Gilks CF, Dye C, et al.: Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009, 373:48–57. This modeling exercise ignited debate regarding what might be possible for epidemic control if universal HIV testing, treatment, and adherence support were fully accessible.CrossRefPubMed •• Granich RM, Gilks CF, Dye C, et al.: Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009, 373:48–57. This modeling exercise ignited debate regarding what might be possible for epidemic control if universal HIV testing, treatment, and adherence support were fully accessible.CrossRefPubMed
29.
Zurück zum Zitat Dodd PJ, Garnett GP, Hallett TB: Examining the promise of HIV elimination by ‘test and treat’ in hyperendemic settings. AIDS 2010, 24:729–735.CrossRefPubMed Dodd PJ, Garnett GP, Hallett TB: Examining the promise of HIV elimination by ‘test and treat’ in hyperendemic settings. AIDS 2010, 24:729–735.CrossRefPubMed
30.
Zurück zum Zitat Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al.: Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009, 361:2209–2220.CrossRefPubMed Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al.: Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009, 361:2209–2220.CrossRefPubMed
31.
Zurück zum Zitat Korenromp EL, White RG, Orroth KK, et al.: Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials. J Infect Dis 2005, 191(Suppl 1):S168–S178.CrossRefPubMed Korenromp EL, White RG, Orroth KK, et al.: Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials. J Infect Dis 2005, 191(Suppl 1):S168–S178.CrossRefPubMed
32.
Zurück zum Zitat Allen S, Tice J, Van de Perre P, et al.: Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa. BMJ 1992, 304:1605–1609.CrossRefPubMed Allen S, Tice J, Van de Perre P, et al.: Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa. BMJ 1992, 304:1605–1609.CrossRefPubMed
33.
Zurück zum Zitat Bunnell R, Cherutich P: Universal HIV testing and counselling in Africa. Lancet 2008, 371:2148–2150.CrossRefPubMed Bunnell R, Cherutich P: Universal HIV testing and counselling in Africa. Lancet 2008, 371:2148–2150.CrossRefPubMed
34.
Zurück zum Zitat Celum CL, Robinson NJ, Cohen MS: Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection. J Infect Dis 2005, 191(Suppl 1):S107–S114.CrossRefPubMed Celum CL, Robinson NJ, Cohen MS: Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection. J Infect Dis 2005, 191(Suppl 1):S107–S114.CrossRefPubMed
35.
Zurück zum Zitat Bassett IV: Integrating HIV screening into routine health care in resource-limited settings. Clin Infect Dis 2010, 50(Suppl 3):S77–S84.CrossRefPubMed Bassett IV: Integrating HIV screening into routine health care in resource-limited settings. Clin Infect Dis 2010, 50(Suppl 3):S77–S84.CrossRefPubMed
36.
Zurück zum Zitat Khumalo-Sakutukwa G, et al.: Project Accept (HPTN 043): a community-based intervention to reduce HIV incidence in populations at risk for HIV in sub-Saharan Africa and Thailand. J Acquir Immune Defic Syndr 2008, 49:422–431.CrossRefPubMed Khumalo-Sakutukwa G, et al.: Project Accept (HPTN 043): a community-based intervention to reduce HIV incidence in populations at risk for HIV in sub-Saharan Africa and Thailand. J Acquir Immune Defic Syndr 2008, 49:422–431.CrossRefPubMed
37.
Zurück zum Zitat Weinhardt LS, et al.: Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985–1997. Am J Public Health 1999, 89:1397–1405.CrossRefPubMed Weinhardt LS, et al.: Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985–1997. Am J Public Health 1999, 89:1397–1405.CrossRefPubMed
38.
Zurück zum Zitat Sherr L, Lopman B, Kakowa M, et al.: Voluntary counselling and testing: uptake, impact on sexual behaviour, and HIV incidence in a rural Zimbabwean cohort. AIDS 2007, 21:851–860.CrossRefPubMed Sherr L, Lopman B, Kakowa M, et al.: Voluntary counselling and testing: uptake, impact on sexual behaviour, and HIV incidence in a rural Zimbabwean cohort. AIDS 2007, 21:851–860.CrossRefPubMed
39.
Zurück zum Zitat Corbett EL, Makamure B, Cheung YB, et al.: HIV incidence during a cluster-randomized trial of two strategies providing voluntary counselling and testing at the workplace, Zimbabwe. AIDS 2007, 21:483–489.CrossRefPubMed Corbett EL, Makamure B, Cheung YB, et al.: HIV incidence during a cluster-randomized trial of two strategies providing voluntary counselling and testing at the workplace, Zimbabwe. AIDS 2007, 21:483–489.CrossRefPubMed
40.
Zurück zum Zitat Huchko MJ, Montandon M, Nguti R, et al.: The association of HIV counseling and testing with HIV risk behaviors in a random population-based survey in Kisumu, Kenya. AIDS Behav 2009 Dec 11 (Epub ahead of print). Huchko MJ, Montandon M, Nguti R, et al.: The association of HIV counseling and testing with HIV risk behaviors in a random population-based survey in Kisumu, Kenya. AIDS Behav 2009 Dec 11 (Epub ahead of print).
41.
Zurück zum Zitat WHO and UNICEF: Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector: Progress report 2009. Geneva, Switzerland: WHO: 2009. WHO and UNICEF: Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector: Progress report 2009. Geneva, Switzerland: WHO: 2009.
42.
Zurück zum Zitat Bunnell R, Ekwaru JP, Solberg P, et al.: Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 2006, 20:85–92.CrossRefPubMed Bunnell R, Ekwaru JP, Solberg P, et al.: Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 2006, 20:85–92.CrossRefPubMed
43.
Zurück zum Zitat Sullivan P, et al.: Is the reduction of HIV transmission risk while prescribed antiretroviral therapy (ARVT) different for men and women? Results from discordant couples in Rwanda and Zambia. In 5th IAS. Cape Town, SA; 2009. Sullivan P, et al.: Is the reduction of HIV transmission risk while prescribed antiretroviral therapy (ARVT) different for men and women? Results from discordant couples in Rwanda and Zambia. In 5th IAS. Cape Town, SA; 2009.
44.
Zurück zum Zitat Donnell D, Baeten JM, Kiarie J, et al.: Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010, 375:2092–2098.CrossRefPubMed Donnell D, Baeten JM, Kiarie J, et al.: Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010, 375:2092–2098.CrossRefPubMed
45.
Zurück zum Zitat Attia S, Egger M, Müller M, et al.: Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009, 23:1397–1404.CrossRefPubMed Attia S, Egger M, Müller M, et al.: Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009, 23:1397–1404.CrossRefPubMed
46.
Zurück zum Zitat Montaner J, Wood E, Kerr T, et al.: Association of expanded HAART coverage with a decrease in new HIV diagnoses, particularly among injection drug users in British Columbia, Canada [Paper 88LB]. Presented at the 17th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA; February 16–19, 2010. Montaner J, Wood E, Kerr T, et al.: Association of expanded HAART coverage with a decrease in new HIV diagnoses, particularly among injection drug users in British Columbia, Canada [Paper 88LB]. Presented at the 17th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA; February 16–19, 2010.
47.
Zurück zum Zitat Das-Douglas M, Chu, Santos GM, et al.: Decreases in community viral load are associated with a reduction in new HIV diagnoses in San Francisco [Paper #33]. Presented at the 17th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA; February 16–19, 2010. Das-Douglas M, Chu, Santos GM, et al.: Decreases in community viral load are associated with a reduction in new HIV diagnoses in San Francisco [Paper #33]. Presented at the 17th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA; February 16–19, 2010.
48.
Zurück zum Zitat Kalichman SC, Di Berto G, Eaton L: Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings. Sex Transm Dis 2008, 35:55–60.CrossRefPubMed Kalichman SC, Di Berto G, Eaton L: Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings. Sex Transm Dis 2008, 35:55–60.CrossRefPubMed
49.
Zurück zum Zitat Amico KR, Harman JJ, Johnson BT: Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr 2006, 41:285–297.CrossRefPubMed Amico KR, Harman JJ, Johnson BT: Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr 2006, 41:285–297.CrossRefPubMed
50.
Zurück zum Zitat Simoni JM, et al.: Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr 2006, 43(Suppl 1):S23–S35.PubMed Simoni JM, et al.: Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr 2006, 43(Suppl 1):S23–S35.PubMed
51.
Zurück zum Zitat WHO: Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents: Geneva, Switzerland: WHO. WHO: Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents: Geneva, Switzerland: WHO.
52.
Zurück zum Zitat Holmes KK, Levine R, Weaver M: Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 2004, 82:454–461.PubMed Holmes KK, Levine R, Weaver M: Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 2004, 82:454–461.PubMed
53.
Zurück zum Zitat Johnson BT, et al.: Sexual risk reduction for persons living with HIV: research synthesis of randomized controlled trials, 1993 to 2004. J Acquir Immune Defic Syndr 2006, 41:642–650.CrossRefPubMed Johnson BT, et al.: Sexual risk reduction for persons living with HIV: research synthesis of randomized controlled trials, 1993 to 2004. J Acquir Immune Defic Syndr 2006, 41:642–650.CrossRefPubMed
54.
Zurück zum Zitat Crepaz N, Lyles CM, Wolitski RJ, et al.: Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS 2006, 20:143–157.CrossRefPubMed Crepaz N, Lyles CM, Wolitski RJ, et al.: Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS 2006, 20:143–157.CrossRefPubMed
55.
Zurück zum Zitat Horvath T, et al.: Interventions for preventing late postnatal mother-to-child transmission of HIV. Cochrane Database Syst Rev 2009, CD006734. Horvath T, et al.: Interventions for preventing late postnatal mother-to-child transmission of HIV. Cochrane Database Syst Rev 2009, CD006734.
56.
Zurück zum Zitat Des Jarlais DC, Marmor M, Paone D, et al.: HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996, 348:987–991.CrossRefPubMed Des Jarlais DC, Marmor M, Paone D, et al.: HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996, 348:987–991.CrossRefPubMed
57.
Zurück zum Zitat Copenhaver MM, Johnson BT, Lee IC, et al.: Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy. J Subst Abuse Treat 2006, 31:163–171.CrossRefPubMed Copenhaver MM, Johnson BT, Lee IC, et al.: Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy. J Subst Abuse Treat 2006, 31:163–171.CrossRefPubMed
58.
Zurück zum Zitat Malta M, Magnanini MM, Strathdee SA, Bastos FI: Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav 2008, 14:731–747.CrossRefPubMed Malta M, Magnanini MM, Strathdee SA, Bastos FI: Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav 2008, 14:731–747.CrossRefPubMed
59.
Zurück zum Zitat Vermund SH, et al.: Addressing research priorities for prevention of HIV infection in the United States. Clin Infect Dis 2010, 50(Suppl 3):S149–S155.CrossRefPubMed Vermund SH, et al.: Addressing research priorities for prevention of HIV infection in the United States. Clin Infect Dis 2010, 50(Suppl 3):S149–S155.CrossRefPubMed
60.
Zurück zum Zitat Zachariah R, Harries AD, Philips M, et al.: Antiretroviral therapy for HIV prevention: many concerns and challenges, but are there ways forward in sub-Saharan Africa? Trans R Soc Trop Med Hyg 2010, 104:387–391.CrossRefPubMed Zachariah R, Harries AD, Philips M, et al.: Antiretroviral therapy for HIV prevention: many concerns and challenges, but are there ways forward in sub-Saharan Africa? Trans R Soc Trop Med Hyg 2010, 104:387–391.CrossRefPubMed
61.
Zurück zum Zitat McCoy SI, Kangwende RA, Padian NS: Behavior change interventions to prevent HIV infection among women living in low and middle income countries: a systematic review. AIDS Behav 2010, 14:469–482.CrossRefPubMed McCoy SI, Kangwende RA, Padian NS: Behavior change interventions to prevent HIV infection among women living in low and middle income countries: a systematic review. AIDS Behav 2010, 14:469–482.CrossRefPubMed
62.
Zurück zum Zitat •• Karim QA, Karim SS, Frohlich JA, et al.: Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010 Jul 19 (Epub ahead of print). This is the first evidence that a topically applied (ART-containing) microbicide can provide protection from HIV among at-risk women: 1% tenofovir gel reduced HIV acquisition by an estimated 39% overall and by 54% in women with high gel adherence. •• Karim QA, Karim SS, Frohlich JA, et al.: Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010 Jul 19 (Epub ahead of print). This is the first evidence that a topically applied (ART-containing) microbicide can provide protection from HIV among at-risk women: 1% tenofovir gel reduced HIV acquisition by an estimated 39% overall and by 54% in women with high gel adherence.
63.
Zurück zum Zitat Mills E, Cooper C, Anema A, Guyatt G: Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11,050 men. HIV Med 2008, 9:332–335.CrossRefPubMed Mills E, Cooper C, Anema A, Guyatt G: Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11,050 men. HIV Med 2008, 9:332–335.CrossRefPubMed
64.
Zurück zum Zitat Weiss HA, Hankins CA, Dickson K: Male circumcision and risk of HIV infection in women: a systematic review and meta-analysis. Lancet Infect Dis 2009, 9:669–677.CrossRefPubMed Weiss HA, Hankins CA, Dickson K: Male circumcision and risk of HIV infection in women: a systematic review and meta-analysis. Lancet Infect Dis 2009, 9:669–677.CrossRefPubMed
65.
Zurück zum Zitat Grosskurth H, Mosha F, Todd J, et al.: Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995, 346:530–536.CrossRefPubMed Grosskurth H, Mosha F, Todd J, et al.: Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995, 346:530–536.CrossRefPubMed
66.
Zurück zum Zitat Ozler B, et al.: Cash payments can reduce HIV/STIs in Africa—New Bank studies. News release No. 2011//027/HDN, at IAS Meeting. Vienna; July 18, 2010. Ozler B, et al.: Cash payments can reduce HIV/STIs in Africa—New Bank studies. News release No. 2011//027/HDN, at IAS Meeting. Vienna; July 18, 2010.
67.
Zurück zum Zitat Merson M, Padian N, Coates TJ, et al.: Combination HIV prevention. Lancet 2008, 372:1805–1806.CrossRefPubMed Merson M, Padian N, Coates TJ, et al.: Combination HIV prevention. Lancet 2008, 372:1805–1806.CrossRefPubMed
68.
Zurück zum Zitat Buse K, Dickinson C, Sidibe M: HIV: know your epidemic, act on its politics. J R Soc Med 2008, 101:572–573.CrossRefPubMed Buse K, Dickinson C, Sidibe M: HIV: know your epidemic, act on its politics. J R Soc Med 2008, 101:572–573.CrossRefPubMed
69.
Zurück zum Zitat Grassly NC, Garnett GP, Schwartländer B, et al.: The effectiveness of HIV prevention and the epidemiological context. Bull World Health Organ 2001, 79:1121–1132.PubMed Grassly NC, Garnett GP, Schwartländer B, et al.: The effectiveness of HIV prevention and the epidemiological context. Bull World Health Organ 2001, 79:1121–1132.PubMed
70.
Zurück zum Zitat Hughes JP, Kulich M: Cluster randomized trials for HIV prevention. Curr Opin HIV AIDS 2006, 1:471–475.CrossRefPubMed Hughes JP, Kulich M: Cluster randomized trials for HIV prevention. Curr Opin HIV AIDS 2006, 1:471–475.CrossRefPubMed
71.
Zurück zum Zitat DeGruttola V, et al.: Developing and evaluating comprehensive HIV infection control strategies: issues and challenges. Clin Infect Dis 2010, 50(Suppl 3):S102–S107.CrossRefPubMed DeGruttola V, et al.: Developing and evaluating comprehensive HIV infection control strategies: issues and challenges. Clin Infect Dis 2010, 50(Suppl 3):S102–S107.CrossRefPubMed
72.
Zurück zum Zitat Anderson RM: Transmission dynamics of sexually transmitted infections. In Sexually Transmitted Diseases, edn 3. Edited by Holmes K, Sparling PF, Mardh PA, et al. New York: McGraw-Hill; 1998. Anderson RM: Transmission dynamics of sexually transmitted infections. In Sexually Transmitted Diseases, edn 3. Edited by Holmes K, Sparling PF, Mardh PA, et al. New York: McGraw-Hill; 1998.
73.
Zurück zum Zitat Kurth A, Spielberg F: Individual-level risk assessment for STD/HIV infection. In Sexually Transmitted Diseases, edn 4. Edited by Holmes K, Sparling PF, Stamm W, et al. New York: McGraw-Hill; 2008. Kurth A, Spielberg F: Individual-level risk assessment for STD/HIV infection. In Sexually Transmitted Diseases, edn 4. Edited by Holmes K, Sparling PF, Stamm W, et al. New York: McGraw-Hill; 2008.
Metadaten
Titel
Combination HIV Prevention: Significance, Challenges, and Opportunities
verfasst von
Ann E. Kurth
Connie Celum
Jared M. Baeten
Sten H. Vermund
Judith N. Wasserheit
Publikationsdatum
01.03.2011
Verlag
Current Science Inc.
Erschienen in
Current HIV/AIDS Reports / Ausgabe 1/2011
Print ISSN: 1548-3568
Elektronische ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-010-0063-3

Weitere Artikel der Ausgabe 1/2011

Current HIV/AIDS Reports 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.